Literature DB >> 1426222

Relationship of the type of tobacco and inhalation pattern to pulmonary and total mortality.

P Lange1, J Nyboe, M Appleyard, G Jensen, P Schnohr.   

Abstract

Data from The Copenhagen City Heart Study, a prospective population study, were analysed to investigate the influence of the type of tobacco and inhalation on pulmonary and total mortality. The study sample comprised 6,511 men and 7,703 women, selected randomly after age-stratification from the general population. There were 2,986 plain cigarette smokers, 3,222 filter cigarette smokers, 1,578 smokers of cheroots/cigars, 433 male pipe smokers and 773 subjects smoking more than one type of tobacco. From 1976 until the end of 1989, 2,765 subjects died. Lung cancer was considered as main death cause in 268. Chronic obstructive pulmonary disease (COPD) was considered as the main cause in 94 cases and main or contributory cause of death in 195 cases (COPD related mortality). Current smokers had a higher risk of total mortality compared to lifetime nonsmokers: the relative risks (RR) ranged between 1.2 for male pipe smokers and 2.4 for female plain cigarette smokers. With regard to lung cancer mortality, the RR ranged between 4.1 for male pipe smokers and 7.9 for female plain cigarette smokers. Even higher RR values were estimated for COPD related mortality. In both sexes, the RR for the investigated end-points were lower in cheroot/cigar smokers and in pipe smokers than in cigarette smokers, but these differences were markedly diminished after an adjustment for the inhalation habit. The present study substantiates the view that tobacco smoking increases pulmonary and total mortality. The small differences between the various types of tobacco are probably caused by different inhalation patterns.

Entities:  

Mesh:

Year:  1992        PMID: 1426222

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Occupational risk factors of lung cancer: a hospital based case-control study.

Authors:  J H Droste; J J Weyler; J P Van Meerbeeck; P A Vermeire; M P van Sprundel
Journal:  Occup Environ Med       Date:  1999-05       Impact factor: 4.402

Review 2.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer.

Authors:  Peter N Lee; Barbara A Forey; Katharine J Coombs
Journal:  BMC Cancer       Date:  2012-09-03       Impact factor: 4.430

Review 3.  Non-cigarette tobacco and the lung.

Authors:  Michael Schivo; Mark V Avdalovic; Susan Murin
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

Review 4.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

5.  Health impact of "reduced yield" cigarettes: a critical assessment of the epidemiological evidence.

Authors:  M J Thun; D M Burns
Journal:  Tob Control       Date:  2001       Impact factor: 7.552

6.  Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8.

Authors:  Jeffrey E Harris; Michael J Thun; Alison M Mondul; Eugenia E Calle
Journal:  BMJ       Date:  2004-01-10

7.  Intensity and inhalation of smoking in the aetiology of laryngeal cancer.

Authors:  Heribert Ramroth; Andreas Dietz; Heiko Becher
Journal:  Int J Environ Res Public Health       Date:  2011-04-01       Impact factor: 3.390

Review 8.  Systematic review of cigar smoking and all cause and smoking related mortality.

Authors:  Cindy M Chang; Catherine G Corey; Brian L Rostron; Benjamin J Apelberg
Journal:  BMC Public Health       Date:  2015-04-24       Impact factor: 3.295

Review 9.  Practical challenges in conducting respiratory studies.

Authors:  Sanjay D Hake; Mahesh L Patil; Tapankumar M Shah; Partha M Gokhale; Viraj Suvarna
Journal:  Perspect Clin Res       Date:  2015 Jan-Mar
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.